Actos litigation is a subject that I have addressed on several occasions. The pending claims continue to move forward. As they progress, we learn more about the manufacturer Takeda’s research and marketing of this diabetes drug to the public.

Last week, Bloomberg revealed that a whistleblower has also filed suit against Actos manufacturer Takeda. Add this lawsuit to the growing number of claims by patients who suffered severe personal injury after taking the drug.

According to the Bloomberg article, the whistleblower lawsuit was filed by a former Takeda medical reviewer who claimed that the company fraudulently under-reported adverse events related to congestive heart failure and also downplayed information related to the link between Actos and bladder cancer. It will be interesting to follow this case which may impact our clients. The company’s own research into this drug will be very important and claims by a whistleblower may lead to more of this corporate information being revealed.

Many of the claims related to Actos have focused on a link with bladder cancer. However, I have also been interested in the developing information concerning congestive heart failure. I will definitely keep a watch on this claim as it progresses.